Search Results - "Buchan, Sarah L."

Refine Results
  1. 1

    Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling by Buchan, Sarah L, Al-Shamkhani, Aymen

    Published in PloS one (18-09-2012)
    “…The TNF-receptor superfamily member CD30 is expressed on normal and malignant lymphocytes, including anaplastic large cell lymphoma (ALCL) cells. CD30…”
    Get full text
    Journal Article
  2. 2

    Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc by Dadas, Osman, Allen, Joel D, Buchan, Sarah L, Kim, Jinny, Chan, H T Claude, Mockridge, C Ian, Duriez, Patrick J, Rogel, Anne, Crispin, Max, Al-Shamkhani, Aymen

    Published in Frontiers in immunology (27-10-2023)
    “…T cell expressed CD27 provides costimulation upon binding to inducible membrane expressed trimeric CD70 and is required for protective CD8 T cell responses…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy by Buchan, Sarah L., Rogel, Anne, Al-Shamkhani, Aymen

    Published in Blood (04-01-2018)
    “…In recent years, monoclonal antibodies (mAbs) able to reinvigorate antitumor T-cell immunity have heralded a paradigm shift in cancer treatment. The most high…”
    Get full text
    Journal Article
  5. 5

    Fcγ receptor-mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies by Rogel, Anne, Ibrahim, Fathima M, Thirdborough, Stephen M, Renart-Depontieu, Florence, Birts, Charles N, Buchan, Sarah L, Preville, Xavier, King, Emma V, Al-Shamkhani, Aymen

    Published in JCI insight (10-10-2022)
    “…New strategies that augment T cell responses are required to broaden the therapeutic arsenal against cancer. CD96, TIGIT, and CD226 are receptors that bind to…”
    Get full text
    Journal Article
  6. 6

    DNA Vaccines to Attack Cancer by Stevenson, Freda K., Ottensmeier, Christian H., Johnson, Peter, Zhu, Delin, Buchan, Sarah L., McCann, Katy J., Roddick, Joanne S., King, Andrew T., McNicholl, Feargal, Savelyeva, Natalia, Rice, Jason

    “…Delivery of antigens by injection of the encoding DNA allows access to multiple antigen-presenting pathways. Knowledge of immunological processes can therefore…”
    Get full text
    Journal Article
  7. 7

    PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8 + T-Cell-Driven Antitumor Immunity by Buchan, Sarah L, Fallatah, Mohannad, Thirdborough, Stephen M, Taraban, Vadim Y, Rogel, Anne, Thomas, Lawrence J, Penfold, Christine A, He, Li-Zhen, Curran, Michael A, Keler, Tibor, Al-Shamkhani, Aymen

    Published in Clinical cancer research (15-05-2018)
    “…PD-1 checkpoint blockade has revolutionized the field of cancer immunotherapy, yet the frequency of responding patients is limited by inadequate T-cell priming…”
    Get full text
    Journal Article
  8. 8
  9. 9

    DNA fusion gene vaccination mobilizes effective anti-leukemic cytotoxic T lymphocytes from a tolerized repertoire by Rice, Jason, Dossett, Michelle L, Öhlén, Claes, Buchan, Sarah L, Kendall, Timothy J, Dunn, Stuart N, Stevenson, Freda K, Greenberg, Philip D

    Published in European journal of immunology (01-08-2008)
    “…The majority of known human tumor-associated antigens derive from non-mutated self proteins. T cell tolerance, essential to prevent autoimmunity, must…”
    Get full text
    Journal Article
  10. 10

    Akt signaling is critical for memory CD8⁺ T-cell development and tumor immune surveillance by Rogel, Anne, Willoughby, Jane E., Buchan, Sarah L., Leonard, Henry J., Thirdborough, Stephen M., Al-Shamkhani, Aymen

    “…Memory CD8⁺ T cells confer long-term immunity against tumors, and anticancer vaccines therefore should maximize their generation. Multiple memory CD8⁺ T-cell…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Differential impact of CD27 and 4-1BB costimulation on effector and memory CD8 T cell generation following peptide immunization by Willoughby, Jane E, Kerr, Jonathan P, Rogel, Anne, Taraban, Vadim Y, Buchan, Sarah L, Johnson, Peter W M, Al-Shamkhani, Aymen

    Published in The Journal of immunology (1950) (01-07-2014)
    “…The factors that determine differentiation of naive CD8 T cells into memory cells are not well understood. A greater understanding of how memory cells are…”
    Get full text
    Journal Article
  13. 13

    Triggering of TNFRSF25 promotes CD8+ T‐cell responses and anti‐tumor immunity by Slebioda, Tomasz J., Rowley, Tania F., Ferdinand, John R., Willoughby, Jane E., Buchan, Sarah L., Taraban, Vadim Y., Al‐Shamkhani, Aymen

    Published in European journal of immunology (01-09-2011)
    “…TNFRSF25 is a member of the TNF receptor superfamily (TNFRSF) that binds to the TNF‐like protein TL1A. Although recent studies have demonstrated a role for…”
    Get full text
    Journal Article
  14. 14

    Death receptor 3 is essential for generating optimal protective CD41 T‐cell immunity against Salmonella by Buchan, Sarah L., Taraban, Vadim Y., Slebioda, Tomasz J., James, Sonya, Cunningham, Adam F., Al‐Shamkhani, Aymen

    Published in European journal of immunology (01-03-2012)
    “…The TNF receptor superfamily member death receptor 3 (DR3) exacerbates Th2‐ and Th17‐cell‐mediated inflammatory and autoimmune conditions, yet no role in host…”
    Get full text
    Journal Article
  15. 15

    CD27 costimulation contributes substantially to the expansion of functional memory CD8+ T cells after peptide immunization by Taraban, Vadim Y., Rowley, Tania F., Kerr, Jonathan P., Willoughby, Jane E., Johnson, Peter M. W., Al‐Shamkhani, Aymen, Buchan, Sarah L.

    Published in European journal of immunology (01-12-2013)
    “…Naive T cells require signals from multiple costimulatory receptors to acquire full effector function and differentiate to long‐lived memory cells. The…”
    Get full text
    Journal Article
  16. 16

    Death receptor 3 is essential for generating optimal protective CD4⁺ T-cell immunity against Salmonella by Buchan, Sarah L, Taraban, Vadim Y, Slebioda, Tomasz J, James, Sonya, Cunningham, Adam F, Al-Shamkhani, Aymen

    Published in European journal of immunology (01-03-2012)
    “…The TNF receptor superfamily member death receptor 3 (DR3) exacerbates Th2- and Th17-cell-mediated inflammatory and autoimmune conditions, yet no role in host…”
    Get full text
    Journal Article
  17. 17

    DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance by Chaise, Coralie, Buchan, Sarah L., Rice, Jason, Marquet, Jeanine, Rouard, Hélène, Kuentz, Mathieu, Vittes, Gisella E., Molinier-Frenkel, Valérie, Farcet, Jean-Pierre, Stauss, Hans J., Delfau-Larue, Marie-Hélène, Stevenson, Freda K.

    Published in Blood (01-10-2008)
    “…The Wilms tumor antigen, WT1, is associated with several human cancers, including leukemia. We evaluated WT1 as an immunotherapeutic target using our proven…”
    Get full text
    Journal Article
  18. 18

    DNA fusion vaccines induce epitope-specific cytotoxic CD8+ T cells against human leukemia-associated minor histocompatibility antigens by RICE, Jason, DUNN, Stuart, PIPER, Karen, BUCHAN, Sarah L, MOSS, Paul A, STEVENSON, Freda K

    Published in Cancer research (Chicago, Ill.) (15-05-2006)
    “…The graft-versus-leukemia effect of allogeneic stem-cell transplantation is believed to be mediated by T-cell recognition of minor histocompatibility antigens…”
    Get full text
    Journal Article
  19. 19

    Distinct Motifs in the Intracellular Domain of Human CD30 Differentially Activate Canonical and Alternative Transcription Factor NF-[kappa]B Signaling by Buchan, Sarah L, Al-Shamkhani, Aymen

    Published in PloS one (18-09-2012)
    “…The TNF-receptor superfamily member CD30 is expressed on normal and malignant lymphocytes, including anaplastic large cell lymphoma (ALCL) cells. CD30…”
    Get full text
    Journal Article
  20. 20